| 0 |
Antileishmanial [EPC] |
2 |
0.0052 |
| 1 |
Lipid-based Polyene Antifungal [EPC] |
34 |
0.0026 |
| 2 |
Nucleoside Analog Antifungal [EPC] |
3 |
0.0021 |
| 3 |
Echinocandin Antifungal [EPC] |
10 |
0.0012 |
| 4 |
Selective T Cell Costimulation Blocker [EPC] |
5 |
0.0011 |
| 5 |
Polyene Antifungal [EPC] |
36 |
0.0009 |
| 6 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
16 |
0.0007 |
| 7 |
Hematopoietic Stem Cell Mobilizer [EPC] |
1 |
0.0007 |
| 8 |
Antimetabolite Immunosuppressant [EPC] |
13 |
0.0006 |
| 9 |
Topoisomerase Inhibitor [EPC] |
38 |
0.0005 |
| 10 |
Azole Antifungal [EPC] |
61 |
0.0004 |
| 11 |
Antimalarial [EPC] |
4 |
0.0004 |
| 12 |
Antiprotozoal [EPC] |
4 |
0.0004 |
| 13 |
Penem Antibacterial [EPC] |
10 |
0.0003 |
| 14 |
CD52-directed Cytolytic Antibody [EPC] |
5 |
0.0003 |
| 15 |
Antiparasitic [EPC] |
1 |
0.0002 |
| 16 |
Pediculicide [EPC] |
1 |
0.0002 |
| 17 |
Alkylating Drug [EPC] |
41 |
0.0002 |
| 18 |
Oxazolidinone Antibacterial [EPC] |
5 |
0.0002 |
| 19 |
Aminoglycoside Antibacterial [EPC] |
7 |
0.0002 |
| 20 |
Nucleoside Metabolic Inhibitor [EPC] |
42 |
0.0002 |
| 21 |
Asparagine-specific Enzyme [EPC] |
2 |
0.0001 |
| 22 |
Allylamine Antifungal [EPC] |
1 |
0.0001 |
| 23 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
17 |
0.0001 |
| 24 |
Tetracycline-class Antibacterial [EPC] |
1 |
0.0001 |
| 25 |
Antimycobacterial [EPC] |
3 |
0.0001 |
| 26 |
Glycopeptide Antibacterial [EPC] |
7 |
0.0001 |
| 27 |
Lipopeptide Antibacterial [EPC] |
1 |
0.0001 |
| 28 |
Purine Antimetabolite [EPC] |
10 |
0.0001 |
| 29 |
CD20-directed Cytolytic Antibody [EPC] |
31 |
0.0001 |
| 30 |
Corticosteroid [EPC] |
121 |
0.0001 |
| 31 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
1 |
0.0001 |
| 32 |
Fluoroquinolone Antibacterial [EPC] |
9 |
0.0001 |
| 33 |
Kinase Inhibitor [EPC] |
37 |
0.0001 |
| 34 |
Central alpha-2 Adrenergic Agonist [EPC] |
3 |
0.0001 |
| 35 |
Rifamycin Antibacterial [EPC] |
2 |
0.0001 |
| 36 |
BCL-2 Inhibitor [EPC] |
3 |
0.0000 |
| 37 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0000 |
| 38 |
Folate Analog Metabolic Inhibitor [EPC] |
16 |
0.0000 |
| 39 |
Complement Inhibitor [EPC] |
2 |
0.0000 |
| 40 |
Integrin Receptor Antagonist [EPC] |
3 |
0.0000 |
| 41 |
Serotonin Reuptake Inhibitor [EPC] |
3 |
0.0000 |
| 42 |
Janus Kinase Inhibitor [EPC] |
5 |
0.0000 |
| 43 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0000 |
| 44 |
Factor Xa Inhibitor [EPC] |
7 |
0.0000 |
| 45 |
P2Y12 Platelet Inhibitor [EPC] |
3 |
0.0000 |
| 46 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
2 |
0.0000 |
| 47 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 48 |
Aldosterone Antagonist [EPC] |
2 |
0.0000 |
| 49 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 50 |
Platelet Aggregation Inhibitor [EPC] |
5 |
0.0000 |
| 51 |
Proteasome Inhibitor [EPC] |
1 |
0.0000 |
| 52 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 53 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
Proton Pump Inhibitor [EPC] |
4 |
0.0000 |
| 55 |
Vitamin D [EPC] |
2 |
0.0000 |
| 56 |
Vitamin B12 [EPC] |
2 |
0.0000 |
| 57 |
Dihydropyridine Calcium Channel Blocker [EPC] |
2 |
0.0000 |
| 58 |
Tumor Necrosis Factor Blocker [EPC] |
6 |
0.0000 |
| 59 |
Thalidomide Analog [EPC] |
3 |
0.0000 |
| 60 |
Vitamin C [EPC] |
2 |
0.0000 |
| 61 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
6 |
0.0000 |
| 62 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 63 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |
| 64 |
Benzodiazepine [EPC] |
1 |
0.0000 |